Episode Details
In this episode Stacey Rivkin, Vice President of Client Solutions & Strategy at H1 joins to discuss Uncut GEMS: how treatment leaders with revolutionize Pharma and where to find them.
Listen to discover:
- Rivkin’s background in the industry
- Some of the changes she’s seen in the pharma, biotech and life sciences industry in the last couple years
- An overview of the different types of key opinion leaders (KOLs) that Medical Affairs teams and Medical Science Liaisons seek out and interact with
- The term Uncut GEMs – what this means, who these people are, and why this segment of KOLs is considered untapped
- How the term KOL can encompass a lot of different providers, and how this is important to diversify the pool of thought leaders that Pharma engages with
Watch
Listen
Sponsored by: H1 (https://www.h1.co/)
To learn more about H1 please use the links below:
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – Facebook – LinkedIn – Twitter – YouTube – Instagram – Newsletter
